Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
₹77,000
Closing Date
19 Jun 2026, 11:00 amClosed
Single Packet
Normal Tender
No
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Rly. Board
Expenditure
General
PH
1 condition
Purchase Orders will be placed on the firms whose quoted product is in the list of products (eligible number of products with approved manufacturing unit only) for which the firm is approved by the Railway Board.
28 conditions · 2 needing a document upload
Firm should attach the outer carton of the product quoted in which the manufacturing unit address should match with that appearing in the approval letter of Railway Board.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
Part payment against part supply is allowed
1 location across Andhra Pradesh · 17,000 Numbers total
AMI No.12.09/2026-27 Insulin Biphasic Aspart Inj (Insulin Aspart and Insulin Aspart Protamine 30/70) Catridge 100IU per mL in 3mL Each (Intermediate Acting Insulin)
82261142~NR
82261142
Limited - Indigenous
Goods
Andhra Pradesh
₹0
₹77,000
19 Jun 2026
4 Jun 2026
1 item · 17,000 Numbers total
GTL_MEDICAL_PH.No.04019_MEDICINE_ONDANSETRON 4 MG TAB/CAP ]
| Delivery Location | State | Quantity |
|---|---|---|
| CMS/RH/GTL, SCR | Andhra Pradesh | 17000.00 Numbers |
| Total | 17,000 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5615616.pdf
ATTACHMENT
5615615.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .